AP-238 is an opioid analgesic drug that was widely used in China to treat pain in cancer patients as of 1986. It is one of the most potent compounds among a series of analgesic acyl piperazine compounds first synthesized and reported in Japan in the 1970s. AP-238 has analgesic potency 4-5times of morphine but with a relatively higher therapeutic index. The drug was initially claimed to be a non-narcotic analgesic. However, subsequent studies have shown bucinnazine and similar acyl piperazines to be potent and selective agonists of μ-opioid receptor (MOR) with relatively low affinity for the δ-opioid receptor and the κ-opioid receptor. In accordance with these studies, results from the intravenous self-administration experiments in rats showed that ap-238 has a marked reinforcing effect with tolerance and dependence quickly developing In addition, the morphine antagonist naloxone reverses the effect of ap-238 and precipitates withdrawal symptoms in ap-238 treated rats further indicating a mechanism of analgesia mediated via selective agonist activity at μ-opioid receptors.
The Product is out of stock. We probably not will renew the stock.
AP-238 [OUT OF STOCK]
- Product Code: AP-238
- Availability: Out Of Stock
-
$160.00
-
- 2 or more $110.00
- 5 or more $70.00
- 10 or more $50.00
- 20 or more $40.00
- 50 or more $25.00
- 100 or more $15.00
- 200 or more $10.00
- 500 or more $8.50
- 1000 or more $6.50